基于Lu的向放射性核素治疗中的剂量率效应和瘤控制概率:一个理论分析
M Galler1, C Chibolela1, F Thiele1
1Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, Berlin, 13353, Germany.
Physics in medicine and biology
|September 18, 2024
概括
向放射性核素疗法 (TRT) 的剂量率模式显著影响瘤控制概率 (TCP),即使总剂量相同. 这一发现对于优化TRT功效至关重要,特别是当DNA修复缓慢时.
科学领域:
- 核医学就是核医学.
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 使用177Lu的向放射性核素治疗 (TRT) 是晚期前列腺癌和神经内分泌瘤的关键治疗方法.
- TRT 疗效分析通常集中在吸收剂量上,忽视了时间剂量-速率动态.
- 了解剂量-速率影响对于推进TRT策略至关重要.
研究的目的:
- 研究TRT中剂量率模式对瘤控制概率 (TCP) 的影响.
- 为了确定剂量-速率的变化是否会影响超出总吸收剂量的治疗结果.
- 强调在TRT疗效分析中考虑时间动态的重要性.
主要方法:
- 一个四周期TRT疗程的数值模拟.
- 使用了机械致命潜在致命 (LPL) 模型.
- 纳入了Zaider-Minerbo模型用于TCP,包括瘤细胞再生.
主要成果:
- 在TRT中的剂量速率模式可以显著影响TCP,独立于总吸收剂量.
- 当潜在的致命性损伤修复缓慢时,这些剂量-速率影响更为明显.
- 剂量输送的时间动态在治疗结果中起着重要作用.
结论:
- TRT 疗效分析应纳入完整的剂量-速率模式,而不仅仅是吸收的剂量.
- 考虑剂量-速率动态对于优化TRT至关重要.
- 这对于新型TRT组合特别重要,例如那些含有DNA损伤修复抑制剂的组合.
更多相关视频
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.1K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
9.9K
相关概念视频
Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
